9
Mar 2026
Most weight lost on GLP-1 drugs returns within a year after stopping
The cessation of GLP-1RAs is linked to a 60% weight regain within a year, emphasizing the importance of tailored strategies for effective long-term weight loss.
9
Mar 2026
The cessation of GLP-1RAs is linked to a 60% weight regain within a year, emphasizing the importance of tailored strategies for effective long-term weight loss.
9
Mar 2026
Humans often adapt their behavior to that of other people with lightning speed. A new study by the University of Zurich reveals what brain networks govern social mentalization and adaptation, making it possible to predict how flexibly one person reacts to others.
9
Mar 2026
Cytotrait, a biotechnology spinout company from The University of Manchester focussed on the development of novel traits for food and agriculture, today announced the close of its £3 M seed funding round.
9
Mar 2026
Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced that it has established a US subsidiary at The Engine in Cambridge, MA.
9
Mar 2026
Researchers have discovered that mutations in the FOXJ3 gene act as a "master switch" failure, disrupting how the brain builds its layers and leading to FCD, a primary cause of drug-resistant epilepsy.
9
Mar 2026
California Gov. Gavin Newsom has positioned himself as a national public health leader by staking out science-backed policies in contrast with the Trump administration.
9
Mar 2026
In states that have long refused to expand Medicaid to more low-income adults, people in the program aren't subject to new rules under the One Big Beautiful Bill Act requiring them to prove they're working in order to get and keep coverage.
9
Mar 2026
This study examines pay dynamics in the NHS, revealing that LGB+ identity disclosure is linked to higher earnings, emphasizing the need for inclusive policies.
9
Mar 2026
Every time we feel a gentle tap on the skin, specialized nerve cells convert that physical force into an electrical signal that the brain can interpret as touch. While scientists have long known that a protein called PIEZO2 acts as a key sensor for touch, it remained unclear why PIEZO2 is specialized for the localized mechanical forces experienced by sensory neurons, whereas its close relative PIEZO1 responds to broader mechanical stresses such as those generated when cells stretch, as occurs in blood vessels.
9
Mar 2026
Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the very early stages of Alzheimer's disease.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more